Breakthrough Innovations in Parkinson's Treatment with Cedars-Sinai & UCLA
12apr6:00 pm7:00 pmBreakthrough Innovations in Parkinson's Treatment with Cedars-Sinai & UCLAApril is Parkinson's Awareness Month
Register Here Did you know that Parkinson’s is the fastest growing neurological disease? Join Kensington Senior Living and leading Movement Disorders Specialists at Cedars-Sinai
Did you know that Parkinson’s is the fastest growing neurological disease? Join Kensington Senior Living and leading Movement Disorders Specialists at Cedars-Sinai & UCLA for an engaging discussion about breakthrough innovations in treatment. Learn the new definition of the disease, how a multi-disciplinary approach has proven successful, and the latest in non-surgical interventions.
At Kensington Senior Living, our promise is to love and care for your family as we do our own. Our expert team specializes in caring for those with movement disorders such as Parkinson’s Disease. We are committed to improving the quality of life for seniors as well as the caregivers who love them.
Michele Tagliati, MD is the Director of the Movement Disorders Program, a Professor of Neurology and Vice Chair of the Department of Neurology at Cedars-Sinai. His research interests include the study of early and advanced therapeutics of Parkinson’s disease, dystonia and other movement disorders. Tagliati pioneered the use of deep brain stimulation in Parkinson’s and dystonia, and his work contributed advances in the definition of outcome predictors and therapeutic settings of DBS. He is currently involved in research on the role of nonmotor and nondopaminergic mechanisms in the pathophysiology of Parkinson’s.
Jeff Bronstein, MD, Ph.D., is the Director of Movement Disorders and a Professor of Neurology at the David Geffen School of Medicine at UCLA. He received his bachelor’s degree from the University of California, Berkeley and M.D. and Ph.D. from UCLA as a recipient of the Medical Scientist Training Program Award. He completed a residency in Neurology and fellowship training in Movement Disorders at UCLA and at Queens Square in London. Dr. Bronstein also completed a postdoctoral fellowship in molecular biology before being appointed Director of the Movement Disorders Program at UCLA in 1996. He directs a basic science laboratory investigating the causes of PD. His clinical interests include the medical and surgical management of Parkinson’s disease (PD), Wilson’s disease and other movement disorders.
For questions, please email Kayla Peters, Outreach Coordinator, at firstname.lastname@example.org.
(Wednesday) 6:00 pm - 7:00 pm EDT
Virtual Zoom Event